EUVIMEDEUVIMED entdecken
Open Access

Clustering Based on Innate Immunity Reveals Differential Dysregulation Based on Disease Severity in Myelodysplastic Neoplasms

Pedro Robson Costa Passos iD, Andréa Alcântara Vieira, Renata Pinheiro Martins de Melo iD, Ronald Feitosa Pinheiro Filho iD, Leonardo Guimarães Sampaio iD, Hermano Vinnicius Gomes Dos Santos iD, Letícia Rodrigues Sampaio iD, João Victor Caetano Goes iD, Sílvia Maria Meira Magalhães iD, Ronald Feitosa Pinheiro iD

Hematological Oncology · 2025

DOI: 10.1002/hon.70104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematological Oncology, 2025. Verfasst von Pedro Robson Costa Passos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Cytogenetics, Federal University of Ceará, Fortaleza, Brazil. Hauptthemen laut MEDLINE: Immunity, Innate, Myelodysplastic Syndromes, Bone Marrow Neoplasms, Leukemia, Myeloid, Acute. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Brazilian Ministry of Science and Technology, National Council for Scientific and Technological Development, UNIVERSAL CNPq/MCTI/FNDCT Nº 18/2021 - Faixa B - Grupos Consolidados.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myelodysplastic neoplasms (MDS) are clonal hematologic disorders characterized by ineffective hematopoiesis and a variable risk of progression to acute myeloid leukemia (AML). Despite growing recognition of the role of innate immunity in MDS pathogenesis, the precise mechanisms remain unclear. In this study, we analyzed bone marrow CD34+ expression data from 183 MDS patients to investigate the impact of the Toll‐like receptor (TLR) pathway on disease progression. Six key innate immunity genes ( IRAK1 , IRAK2 , IRAK4 , MYD88 , TRAF6 , and NFKB1 ) were used to define two distinct immune clusters: a hyperactive immune cluster (HIC) and a moderate immune cluster (MIC). The HIC was enriched in 155 immune‐related pathways and showed higher infiltration of activated natural killer cells and M1 macrophages, while the MIC exhibited increased infiltration of naïve B cells and mast cells. Differential expression analysis identified 35 genes that distinguished the clusters. Validation in an independent cohort of 82 patients revealed that reduced expression of these genes correlated with markers of advanced disease, including lower hemoglobin levels, lower neutrophil counts, altered cytogenetics, and higher bone marrow blast percentages. These findings underscore the critical role of immune dysregulation in MDS progression and highlight novel therapeutic opportunities within the innate immunity pathway for tailored interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateMyelodysplastic SyndromesBone Marrow NeoplasmsLeukemia, Myeloid, AcuteGene Expression RegulationBrazilCluster AnalysisDatasets as TopicToll-Like ReceptorsSignal TransductionAntigens, CD34Disease ProgressionHumansInterleukin-1 Receptor-Associated KinasesCytogenetic AnalysisSeverity of Illness IndexIntracellular Signaling Peptides and ProteinsNF-kappa B p50 SubunitMyeloid Differentiation Factor 88

Stichwörter der Autor:innen

gene expressioninnate immunityirak kinasesmyelodysplastic syndromestoll‐like receptor

Substanzen

Toll-Like ReceptorsAntigens, CD34NFKB1 protein, humanIRAK1 protein, humanInterleukin-1 Receptor-Associated KinasesMYD88 protein, humanTifab protein, humanIntracellular Signaling Peptides and ProteinsNF-kappa B p50 SubunitMyeloid Differentiation Factor 88

Autor:innen und Institutionen

  • Laboratory of Cancer Cytogenetics, Federal University of Ceará, Fortaleza, Brazil.
  • Research Center for Drug Development (NPDM), Fortaleza, Brazil.
  • Postgraduate Program in Medical Sciences, Federal University of Ceará, Fortaleza, Brazil.
  • Postgraduate Program in Pathology, Federal University of Ceará, Fortaleza, Brazil.
  • Department of Clinical Medicine, Federal University of Ceará, Fortaleza, Brazil.

ORCID-Profile: Pedro Robson Costa Passos, Renata Pinheiro Martins de Melo, Ronald Feitosa Pinheiro Filho, Leonardo Guimarães Sampaio, Hermano Vinnicius Gomes Dos Santos, Letícia Rodrigues Sampaio, João Victor Caetano Goes, Sílvia Maria Meira Magalhães, Ronald Feitosa Pinheiro

Förderung

  • Brazilian Ministry of Science and Technology
  • National Council for Scientific and Technological Development
  • UNIVERSAL CNPq/MCTI/FNDCT Nº 18/2021 - Faixa B - Grupos Consolidados
  • Novas tecnologias em Biotecnologia
  • Instituto Nacional de Ciência e Tecnologia do Sangue
  • National Program for Support to Oncology Care
  • Chamada CNPq Nº 4/2021 - Bolsas de Produtividade em Pesquisa - PQ

Zitieren

APA

Passos, P. R. C., Vieira, A. A., de Melo, R. P. M., Pinheiro Filho, R. F., Sampaio, L. G., Santos, H. V. G. D., Sampaio, L. R., Goes, J. V. C., Magalhães, S. M. M., & Pinheiro, R. F. (2025). Clustering Based on Innate Immunity Reveals Differential Dysregulation Based on Disease Severity in Myelodysplastic Neoplasms. Hematological Oncology. https://doi.org/10.1002/hon.70104

Vancouver

Passos PRC, Vieira AA, de Melo RPM, Pinheiro Filho RF, Sampaio LG, Santos HVGD, et al. Clustering Based on Innate Immunity Reveals Differential Dysregulation Based on Disease Severity in Myelodysplastic Neoplasms. Hematological Oncology. 2025. doi:10.1002/hon.70104

BibTeX
@article{Passos2025,
  author = {Passos, Pedro Robson Costa and Vieira, Andréa Alcântara and de Melo, Renata Pinheiro Martins and Pinheiro Filho, Ronald Feitosa and Sampaio, Leonardo Guimarães and Santos, Hermano Vinnicius Gomes Dos and Sampaio, Letícia Rodrigues and Goes, João Victor Caetano and Magalhães, Sílvia Maria Meira and Pinheiro, Ronald Feitosa},
  title = {Clustering Based on Innate Immunity Reveals Differential Dysregulation Based on Disease Severity in Myelodysplastic Neoplasms},
  journal = {Hematological Oncology},
  year = {2025},
  doi = {10.1002/hon.70104}
}
Kostenlos starten →